Spironolactone for reducing proteinuria in diabetic nephropathy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Spironolactone (Primary)
- Indications Diabetic nephropathies; Proteinuria
- Focus Therapeutic Use
- 17 Oct 2008 Biomarkers information updated
- 01 Apr 2008 Results have been published in the Journal of Investigative Medicine.
- 27 Aug 2007 The expected completion date for this trial is now 1 Jun 2006.